Opioids: pain relief, addiction and overdose risk

Opioids are a group of substances that act on opioid receptors. They can be natural or synthetic; some are used for pain relief. When someone takes a prescribed medicine, it matters what pain is being treated, what the medicine provides, what difficulties arise and how medical supervision works. Real relief deserves attention: losing the ability to work or sleep because of pain can also be a serious problem. CDC on prescription opioids

A prescription does not remove every risk. Yet the presence of risk does not make every prescription a mistake or establish a use disorder. Nonmedical use cannot be assessed from a substance's name alone either: known circumstances, the person's condition, control and consequences matter. Keeping these distinctions allows a conversation without accusation or automatic justification.

Tolerance and physical dependence can develop with opioid use. Tolerance means a change in the response to a previously experienced effect; physical dependence involves the body's adaptation and the possibility of withdrawal symptoms when use changes. Neither is a reason to increase a dose independently or test oneself through abrupt discontinuation.

Opioid use disorder is assessed through a broader pattern of life and use. Difficulties with control, continuing despite harm and other circumstances explored in a clinical assessment matter. CDC specifically explains that tolerance and withdrawal are not counted as the corresponding diagnostic criteria when opioids are taken solely under appropriate medical supervision. This is a limited assessment rule, not a claim that a disorder is impossible whenever a prescription exists. CDC on assessing opioid use disorder

It is therefore more useful to understand what is happening than to argue over whether a person is “addicted” on the basis of one sign. “From a pharmacy” does not replace assessment, and “narcotic” does not erase possible therapeutic benefit.

Someone may sincerely say, “With this, I can live and work.” Their experience does not have to be dismissed in advance. However, feeling better and completing tasks do not automatically show how control is changing or whether dangerous consequences are present. A subjective sense of clarity also differs from measured preservation of thinking.

An assessment needs to hold both sides in view: what helps and what becomes harder. For example, has ordinary life become organised solely around obtaining a substance, are there consequences that someone feels they must hide, and is prescribed medicine still being used as agreed with the clinician? These are questions for a conversation, not a home diagnostic scale.

Risks can change when opioids are combined with alcohol and other substances that depress the central nervous system, including benzodiazepines. This specific risk does not mean that all medicines are alike. It calls for telling a professional what is being taken and discussing safety, rather than independently stopping necessary treatment. A prescription and high tolerance do not guarantee protection. CDC on risks and discussing treatment

If someone cannot be awakened, breathing is seriously impaired or an overdose is suspected, immediate local emergency help is needed. There is no need first to establish an opioid use disorder, identify the full contents of a substance or obtain agreement to long-term treatment. If it is safe, stay with the person and follow the emergency service's instructions.

Naloxone is a medicine that can reverse an opioid overdose. It is not a universal antidote for every substance and does not replace emergency help. Ask a local medical professional or pharmacist in advance about availability, how to obtain it and correct use. This article provides no administration schedule, doses or promise that one medicine will resolve the entire situation. CDC on naloxone and overdose

Immediate danger of suicide or self-harm also requires urgent help, regardless of why substances are being used. This article does not enable someone to assess that risk independently. Protecting life comes before notes or finding a suitable programme. NIMH on urgent help

When an assessment establishes opioid use disorder, care involves more than getting through withdrawal. CDC advises against detoxification as the sole treatment of the disorder without medication for it. In its clinical overview, medication treatment is associated with lower overdose risk and mortality. This is a summary of the source, not a guarantee of an individual outcome or a prescription for home treatment. CDC on treating opioid use disorder

Maintenance treatment does not become a moral failure because it continues. Its purpose, safety and results should be assessed, instead of demanding life without medicines at any cost. Psychological and social support may be important; however, CDC states that declining such help or its unavailability should not prevent or delay medication treatment for the disorder.

A person who continues to use may also need care and additional support. They do not first have to prove perfect motivation, eliminate every doubt or find a final purpose in life. The method, medicine and treatment conditions are chosen with a professional; a description of the US system does not confirm that these options are available everywhere.

Pain does not disappear from the conversation when questions arise about opioid safety or addictive behaviour. For someone already receiving opioid therapy, CDC describes shared discussion of benefits and risks and warns against abrupt discontinuation in the absence of a life-threatening situation. This is a clinical framework, not a personal plan to continue, increase or reduce a dose. CDC on continuing opioid therapy

Suspected overdose calls for the urgent route described earlier. In an ordinary discussion, it is useful to tell the prescribing professional about pain, changes in functioning, difficulties taking the medicine and other substances. These issues can be addressed together: pain care and assessment of a use disorder should not become an argument about what harm a person is expected to endure.

You can begin with the clinician prescribing treatment, an accessible primary care professional or a service that works with substance use problems. A first request can be simple: “I need to discuss opioids, pain and safety. I am unsure what is happening and want to understand the next step.” Ask what the service assesses and where it refers people when another kind of care is needed. SAMHSA on preparing an appointment

If there is no emergency now, you can prepare five short fields. This is an author-created way of gathering already known information, not a test, diagnosis or condition for accessing treatment. Do not change use or test tolerance to complete it.

1. What is known: the prescribed medicine or known product name and the purpose of use; mark unknown information explicitly as unknown.
2. What helps: pain, everyday activities and relief; what feels frightening to lose if things change.
3. What concerns you: known consequences, difficulties with control, symptoms, previous changes and help received.
4. What matters to disclose: other medicines and substances, known medical conditions; language, money, time, travel and privacy as real constraints.
5. What to ask: a safe next step, care options, follow-up, local conditions, costs and whom to contact if things worsen.

Fields may remain empty. You do not need to find the exact explanation or reconstruct the whole history in advance. Information-sharing rules can be clarified before a routine appointment; emergency care should not wait for every organisational question to be resolved.

A loved one can help arrange an appointment, get there or write down questions if the person agrees. Discuss what help can realistically be provided and what support the helper needs. Participation does not mean becoming the only professional or taking responsibility for the outcome. SAMHSA on caring for the helper

Children must not be assigned to dispense medicines, monitor use or prevent an adult's crisis. Violence calls for separate attention to safety; recovery does not require someone to tolerate danger, forgive or renew contact. Where there is immediate danger, protecting life comes first.

After a first contact, another professional, continuing treatment and reassessment of the plan may be needed. Work, relationships, surroundings and purpose in life can support change, but medical care does not wait until they have all been reorganised. The first practical result here is smaller than a promise to “fix everything”: recognise urgency, choose an accessible contact and discuss a safe next step.

• CDC — About Prescription Opioids, 10 June 2025. The main passage on pain relief, adaptation, risks and shared discussion of treatment was read; not every study or prescribing document.
• CDC — Opioid Use Disorder: Diagnosis, 16 April 2024. Clinical assessment distinctions and the qualification about appropriate medical supervision are applied. No diagnostic scale is reproduced.
• CDC — 5 Things to Know About Naloxone, 2 May 2024. The main passage on urgency, the medicine's purpose and obtaining help was read; not an administration protocol or evidence of local availability.
• CDC — Opioid Use Disorder: Treating, 9 April 2024. The main clinical overview was read; not every linked guideline and study. Care options are not prescribed to the reader.
• CDC — Continuing Opioid Therapy, 7 May 2024. A limited passage on shared discussion of benefits and risks was read; not the full guideline or a dose-change plan.
• SAMHSA — How to Set Up an Appointment, 24 April 2023. A previously read, complete official expanded search response was used; direct HTML reading is not claimed.
• SAMHSA — Caring for Yourself When Helping Someone Else, 24 April 2023. The same reading limit applies; only feasible help and support for the helper are used.
• NIMH — Depression, revised 2024. A previously read passage on urgent help for danger to life is applied; metadata was confirmed separately. This is not a diagnosis of depression from substance use.

The five fields and example request were created by the authors. They are not the project owner's personal history, a validated clinical instrument or a treatment plan. The text does not establish the legal or organisational conditions of care in a particular country.

opioids, pain relief, prescription medicines, nonmedical use, physical dependence, tolerance, opioid use disorder, overdose, naloxone, medication treatment, first contact, loved ones

Andrey Zarinsh is the author and founder of United Wisdom. He explores inner transformation, the unity of traditions, intercultural dialogue and contemporary spiritual discipline. Instagram: @andrey.zarinsh.

Maria Evilkut is a co-author of United Wisdom. Alongside her research, she aims to test these ideas in practice and observe how the principles of unity and mutual understanding work in real life between people and cultures. Instagram: @ilkutki.

Content reviewed: 14 October 2026. English version.